These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 10438370

  • 1. Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis.
    Kole L, Das L, Das PK.
    J Infect Dis; 1999 Sep; 180(3):811-20. PubMed ID: 10438370
    [Abstract] [Full Text] [Related]

  • 2. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N, Mukherjee S, Das L, Das PK.
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [Abstract] [Full Text] [Related]

  • 3. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H, Hockertz S.
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [Abstract] [Full Text] [Related]

  • 4. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
    Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.
    J Infect Dis; 2003 Aug 01; 188(3):458-64. PubMed ID: 12870129
    [Abstract] [Full Text] [Related]

  • 5. Targeting of parasite-specific immunoliposome-encapsulated doxorubicin in the treatment of experimental visceral leishmaniasis.
    Mukherjee S, Das L, Kole L, Karmakar S, Datta N, Das PK.
    J Infect Dis; 2004 Mar 15; 189(6):1024-34. PubMed ID: 14999606
    [Abstract] [Full Text] [Related]

  • 6. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R, Majumder N, Bhattacharyya Majumdar S, Bhattacharjee S, Banerjee S, Roy S, Majumdar S.
    Scand J Immunol; 2007 Dec 15; 66(6):671-83. PubMed ID: 18021365
    [Abstract] [Full Text] [Related]

  • 7. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T, Anam K, Ali N.
    Vaccine; 2004 Mar 12; 22(9-10):1162-71. PubMed ID: 15003644
    [Abstract] [Full Text] [Related]

  • 8. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL, Antúnez MI, Abrami AA.
    Medicina (B Aires); 1999 Mar 12; 59 Suppl 2():84-90. PubMed ID: 10668248
    [Abstract] [Full Text] [Related]

  • 9. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response.
    Das L, Datta N, Bandyopadhyay S, Das PK.
    J Immunol; 2001 Mar 15; 166(6):4020-8. PubMed ID: 11238649
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potential of doxorubicin as an antileishmanial agent.
    Sett R, Basu N, Ghosh AK, Das PK.
    J Parasitol; 1992 Apr 15; 78(2):350-4. PubMed ID: 1556650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease.
    Sett R, Sarkar K, Das PK.
    J Infect Dis; 1993 Oct 15; 168(4):994-9. PubMed ID: 8376846
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4.
    Stenger S, Solbach W, Röllinghoff M, Bogdan C.
    Eur J Immunol; 1991 Jul 15; 21(7):1669-75. PubMed ID: 1905642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.